These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1639222)

  • 1. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
    Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
    Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
    Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
    J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.
    Mitsuyama K; Toyonaga A; Sasaki E; Ishida O; Ikeda H; Tsuruta O; Harada K; Tateishi H; Nishiyama T; Tanikawa K
    Gut; 1995 Jan; 36(1):45-9. PubMed ID: 7890234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
    Mueller C; Knoflach P; Zielinski CC
    Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circulating common gamma chain (CD132) in inflammatory bowel disease.
    Nielsen OH; Kirman I; Johnson K; Giedlin M; Ciardelli T
    Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease.
    Hosomi S; Yamagami H; Itani S; Yukawa T; Otani K; Nagami Y; Tanaka F; Taira K; Kamata N; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
    J Crohns Colitis; 2018 Jan; 12(1):87-95. PubMed ID: 28961693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.
    Brynskov J; Tvede N; Andersen CB; Vilien M
    Gut; 1992 Jan; 33(1):55-8. PubMed ID: 1740278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease.
    Gross V; Andus T; Caesar I; Roth M; Schölmerich J
    Gastroenterology; 1992 Feb; 102(2):514-9. PubMed ID: 1370661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
    Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
    Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors].
    Duclos B; Reimund JM; Lang JM; Coumaros G; Chamouard P; Lehr L; Baumann R; Koehl C; Weill JP
    Gastroenterol Clin Biol; 1990; 14(1):22-7. PubMed ID: 2311849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
    Kucharzik T; Stoll R; Lügering N; Domschke W
    Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study.
    Mavropoulou E; Mechie NC; Knoop R; Petzold G; Ellenrieder V; Kunsch S; Pilavakis Y; Amanzada A
    PLoS One; 2020; 15(5):e0233811. PubMed ID: 32470973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease.
    Street ME; de'Angelis G; Camacho-Hübner C; Giovannelli G; Ziveri MA; Bacchini PL; Bernasconi S; Sansebastiano G; Savage MO
    Horm Res; 2004; 61(4):159-64. PubMed ID: 14691340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease.
    Holtkamp W; Stollberg T; Reis HE
    J Clin Gastroenterol; 1995 Mar; 20(2):123-6. PubMed ID: 7769191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission.
    Van Kemseke C; Belaiche J; Louis E
    Int J Colorectal Dis; 2000 Aug; 15(4):206-10. PubMed ID: 11008719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.